Assess the Safety and Tolerability of SNS851 in Healthy Participants

Clinical trial NCT07417124 · RECRUITING

Trial details

NCT number: NCT07417124
Sponsor: Oneness Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metabolic Disease

Start date: 2026-04-01
Primary completion: 2026-10-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.